Impact of Residual Nodal Disease Burden on Technical Outcomes of Sentinel Lymph Node Biopsy for Node-Positive (cN1) Breast Cancer Patients Treated with Neoadjuvant ChemotherapyAlison Laws, Tari A. King, Laura S. Dominici et al.|Annals of Surgical Oncology|2019Cited by 29
Impact of residual nodal disease burden on sentinel node mapping and accuracy of intraoperative frozen section in node positive (cN1) breast cancer patients treated with neoadjuvant chemotherapy (NAC).Alison Laws, Tari A. King, Melissa E. Hughes et al.|Journal of Clinical Oncology|2018Cited by 1